[go: up one dir, main page]

AR227879A1 - Procedimiento para preparar derivados de la 8-halo o nitro-4h,6h-(1,2,4-triazol)(4,3,a)(4,1)benzoxabepina - Google Patents

Procedimiento para preparar derivados de la 8-halo o nitro-4h,6h-(1,2,4-triazol)(4,3,a)(4,1)benzoxabepina

Info

Publication number
AR227879A1
AR227879A1 AR279045A AR27904579A AR227879A1 AR 227879 A1 AR227879 A1 AR 227879A1 AR 279045 A AR279045 A AR 279045A AR 27904579 A AR27904579 A AR 27904579A AR 227879 A1 AR227879 A1 AR 227879A1
Authority
AR
Argentina
Prior art keywords
benzoxabepine
triazol
halo
nitro
procedure
Prior art date
Application number
AR279045A
Other languages
English (en)
Spanish (es)
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of AR227879A1 publication Critical patent/AR227879A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/36—Seven-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AR279045A 1978-11-27 1979-11-27 Procedimiento para preparar derivados de la 8-halo o nitro-4h,6h-(1,2,4-triazol)(4,3,a)(4,1)benzoxabepina AR227879A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14694978A JPS5572177A (en) 1978-11-27 1978-11-27 4,1-benzoxazepine or 4,1-benzothiazepine

Publications (1)

Publication Number Publication Date
AR227879A1 true AR227879A1 (es) 1982-12-30

Family

ID=15419209

Family Applications (1)

Application Number Title Priority Date Filing Date
AR279045A AR227879A1 (es) 1978-11-27 1979-11-27 Procedimiento para preparar derivados de la 8-halo o nitro-4h,6h-(1,2,4-triazol)(4,3,a)(4,1)benzoxabepina

Country Status (21)

Country Link
US (2) US4297280A (sv)
JP (1) JPS5572177A (sv)
AR (1) AR227879A1 (sv)
AU (1) AU533517B2 (sv)
BE (1) BE880282A (sv)
CA (1) CA1127639A (sv)
CH (1) CH642647A5 (sv)
DD (1) DD147360A5 (sv)
DE (1) DE2947773A1 (sv)
DK (1) DK500179A (sv)
ES (4) ES8102106A1 (sv)
FR (1) FR2442239A1 (sv)
GB (1) GB2046729B (sv)
HU (1) HU179589B (sv)
IT (1) IT1165246B (sv)
MX (1) MX6217E (sv)
NL (1) NL7908596A (sv)
NZ (1) NZ192092A (sv)
SE (1) SE7909751L (sv)
SU (2) SU936815A3 (sv)
ZA (1) ZA796040B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374842A (en) * 1980-04-18 1983-02-22 Shionogi & Co., Ltd. 4,1-Benzoxazepines and compositions
JPS5759893A (en) * 1980-09-29 1982-04-10 Shionogi & Co Ltd 4,1-benzoxazepin derivative
CA1211437A (en) * 1981-08-12 1986-09-16 Rene Borer Benzazepines
US4590187A (en) * 1983-11-17 1986-05-20 The Upjohn Company Phospholipase A2 inhibition using 4,1-benzoxazepine-2-(3H)-ones
US4897392A (en) * 1989-07-03 1990-01-30 Hoechst-Roussel Pharmaceuticals, Inc. 4H-indolo(1,2-d)(1,2,4)triazolo(4,3-A)(1,4)benzodiazepines
US5552399A (en) * 1994-11-02 1996-09-03 Janssen Pharmaceutica N.V. Substituted tetracyclic azepine derivatives
US6063921A (en) * 1997-11-20 2000-05-16 Pharm-Eco Laboratories, Inc. Synthesis of 11-aryl-5,6-dihydro-11H-dibenz[b,e]azepines
RU2266906C1 (ru) * 2004-04-29 2005-12-27 Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия") Анелированные карбамоилазагетероциклы, способы их получения (варианты), фармацевтическая композиция, фокусированная библиотека

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1090611A (en) * 1963-05-22 1967-11-08 Lepetit Spa 4,1-benzoxazepine derivatives
DE1545639A1 (de) * 1965-11-19 1969-08-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Derivaten des 3,5-Dihydro-4,1-Benzothiazepin-2[1 H]-ons
BE793629A (fr) * 1972-01-03 1973-07-03 Upjohn Co Nouveaux derives de benzodiazepines et leur preparation
JPS5084590A (sv) * 1973-11-28 1975-07-08
US4000151A (en) * 1974-09-11 1976-12-28 The Upjohn Company Triazolyl benzophenone compounds
US3933816A (en) * 1974-09-12 1976-01-20 The Upjohn Company 3-(Substituted aminomethyl)-7-substituted-3,5-dihydro-as-triazino[4,3-a][1,5]benzodiazepines
US3966756A (en) * 1975-04-07 1976-06-29 American Cyanamid Company Substituted dibenzo[b,f]tetrazolo[1,5-d][1,4]-oxazepines
US4246270A (en) * 1976-05-26 1981-01-20 E. I. Du Pont De Nemours And Company 3-Fluorobenzodiazepines and compositions and uses thereof
US4207322A (en) * 1975-11-04 1980-06-10 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler 6-Aryl-s-triazolo-(4,3-alpha)-pyrido-(2,3-f)-(1,4)-diazepines
US4180668A (en) * 1977-06-08 1979-12-25 The Upjohn Company Piperidino-4H-s-triazolo[4,3-a][1,4]benzodiazepines
JPS54119499A (en) * 1978-03-09 1979-09-17 Shionogi & Co Ltd Triazolobenzodiazepin derivative

Also Published As

Publication number Publication date
FR2442239B1 (sv) 1983-07-01
AU5299379A (en) 1980-05-29
ES486328A0 (es) 1980-12-16
CH642647A5 (de) 1984-04-30
MX6217E (es) 1984-12-21
ZA796040B (en) 1980-10-29
BE880282A (fr) 1980-03-17
IT1165246B (it) 1987-04-22
GB2046729A (en) 1980-11-19
DD147360A5 (de) 1981-04-01
AU533517B2 (en) 1983-12-01
NL7908596A (nl) 1980-05-29
DE2947773A1 (de) 1980-06-04
ES8102106A1 (es) 1980-12-16
DK500179A (da) 1980-05-28
ES493759A0 (es) 1981-08-01
HU179589B (en) 1982-11-29
IT7969279A0 (it) 1979-11-26
CA1127639A (en) 1982-07-13
JPS5572177A (en) 1980-05-30
FR2442239A1 (fr) 1980-06-20
ES493761A0 (es) 1981-08-01
SU1005660A3 (ru) 1983-03-15
GB2046729B (en) 1983-01-26
SU936815A3 (ru) 1982-06-15
SE7909751L (sv) 1980-05-28
NZ192092A (en) 1984-07-31
ES8106730A1 (es) 1981-08-01
US4297280A (en) 1981-10-27
JPS6231719B2 (sv) 1987-07-09
ES8106731A1 (es) 1981-08-01
ES493760A0 (es) 1981-08-01
US4341704A (en) 1982-07-27
ES8106729A1 (es) 1981-08-01

Similar Documents

Publication Publication Date Title
AR222481A1 (es) Procedimiento para obtener derivados de 1-(omega-alcanoiltio o omega-mercaptoalconoil)3,4-deshidroprolina
MX7199E (es) Procedimiento para preparar derivados de 3-cetodelta-4,9,19-nor-esteroides
ES496442A0 (es) Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina
ES496441A0 (es) Un procedimiento para la preparacion de nuevos derivados transisomericos de 4-fenil-1,2,3,4- tetrahidro-1-naftalenamina.
AR225939A1 (es) Un procedimiento para preparar derivados de 1-hidroxi-3-alquilo-6,6-dimetil-9-amino o 9-piperidino o 9-morfolino-6a,7,8,9,10a-hexahidro-6n-dibenzo-(b,d)pirano
AR227288A1 (es) Un procedimiento para la preparacion de derivados de 2,3-difenil-5-(trifluormetiltio o trifuormetilsulfonil)-tiofeno
ES512852A0 (es) "un procedimiento para preparar nuevos derivados de la n-dihidrotiazolil-3-quinolein-carboxamida".
ES508025A0 (es) "procedimiento para preparar derivados de dihidropiridina".
AR221732A1 (es) Procedimiento para la obtencion de 2,6-dialquil-n-(pirazol o 4,5-dihaloimidazolmetil)-2-halo acetanilidas
AR227879A1 (es) Procedimiento para preparar derivados de la 8-halo o nitro-4h,6h-(1,2,4-triazol)(4,3,a)(4,1)benzoxabepina
BR7900352A (pt) Processo para a preparacao de 1,2,4-triazol
ES530574A0 (es) Procedimiento para preparar derivados de pirazol 1,5-a-piridina
ES492115A0 (es) Un procedimiento para la preparacion de 10, 11-dihidro-5-h- dibenzo (a,d) ciclohepten -5,10-iminas
ES495819A0 (es) Procedimiento de preparar derivados 1,2,4-oxadiazolin-5-oni-cos
MX159288A (es) Procedimiento para la preparacion de derivados de 3,7-diazabisiclo(3,3-1)nonano
ES512397A0 (es) "procedimiento para preparar derivados de nicotinoilbenzoguanamina".
ES546802A0 (es) Procedimiento para preparar derivados de 7-oxo-4-tia-1-aza- biciclo(3,2,0)hept-2-eno
ES486989A0 (es) Un procedimiento para preparar derivados de la 4- dehidropi-ridina.
ES532808A0 (es) Un procedimiento para preparar derivados de 7-oxo-4-tia-1-azabiciclo (3.2.0) hep-2-eno
AR229096A1 (es) Procedimiento para preparar octahidro-1h-pirrolo(2,3-g)isoquinolin-4-onas
ES498146A0 (es) Un procedimiento para preparar derivados de 2,2-dicloroace- tamida
ES513398A0 (es) "un procedimiento para preparar derivados de dialcohilpirazol".
MX6219E (es) Procedimiento para preparar derivados de 1,1'-bifenil-2-il-alquilamina
AR225937A1 (es) Procedimiento para preparar derivados de(amino-3-hidroxi-2-propoxi)-imino-4-tetrahidro-4,5,6,7-benzo(b),o tetrihidro-5,6,7,8-4h ciclopenta(b)-o dihidro 5,6,-4h-ciclopenta(b)-tiofeno
PT70387A (el) Process for preparing new acyl-1h-1,2,4-triazole derivatives